Raleigh’s RedHill Biopharma approved for US COVID-19 study
May 08, 2020
OHSU is part of a Phase 2a clinical trial recently approved by the FDA to test a RedHill Biopharma investigational drug’s effectiveness as a COVID-19 treatment.